Capsule review on bioanalytical method transfer: Opportunities and challenges for chromatographic methods

Bioanalysis

Volumn 3, Issue 1, 2011, Pages 57-66

  Lin, Zhongping John ^a   Li, Wenkui ^b   Weng, Naidong ^c  

^a Frontage Laboratories   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; DRUG DETERMINATION; DRUG INDUSTRY; DRUG RESEARCH; FILE TRANSFER PROTOCOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFORMATION PROCESSING; INSTRUMENT VALIDATION; INTERDISCIPLINARY COMMUNICATION; MASS SPECTROMETRY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SAMPLING; SENSITIVITY AND SPECIFICITY; SYSTEMATIC ERROR;

CHROMATOGRAPHY, LIQUID; EVALUATION STUDIES AS TOPIC; GUIDELINES AS TOPIC; LABORATORIES; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN; TECHNOLOGY TRANSFER; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79951933086     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.168     Document Type: Review

References (12)

1. Gilbert MT, Barinov-Colligon I, Miksic JR. Crossvalidation of bioanalytical methods between laboratories. J. Pharm. Biomed. Anal. 13, 385-394 (1995).
2. Rozet E, Dewe W, Ziemons E, Boukloze A, Boulanger B, Hubert P. Methodologies for the transfer of analytical methods: a review. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2214-2223 (2009).
3. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Workshop/conference report. Pharm. Res. 24(10), 1962-1973 (2007). (Pubitemid 47389236)
4. Dewe W. Review of statistical methodologies used to compare (bio)assay. J. Chromatogr. B Analyt.Technol. Biomed. Life Sci. 877, 2208-2213 (2009).
5. Rozet E, Dewe W, Morello R et al. Risk-based approach for the transfer of quantitative methods: bioanalytical applications. J. Chromatogr. A 1189(1-2), 32-43 (2008).
6. Gansser D. Experience with a crossvalidation approach. Chromatographia 55, S71-S74 (2002).
7. Muirhead, Smart TS. Cross validation in bioanalysis: why, when, and how? Chromatographia 52, S72-S75 (2000).
8. Shah KA, Karnes HT. A proposed fixed range decision criteria for transfer of bioanalytical methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2270-2274 (2009).
9. Tartarewicz S, Moxness M, Weeraratne D et al. A step-wise approach for transfer of immunogenicity assays during clinical drug development. AAPS J. 11, 526-534 (2009).
10. Klump W, Hill H. Strategies for successful transfer of ligand-binding assays for successful validation and implementation in GXP environment. In: Ligand-Binding Assays - Development, Validation and Implementation in the Drug Development Arena. Khan MN, Findlay JW (Eds). John Wiley & Sons, Hoboken, NJ, USA 265-186 (2010).
11. US FDA. Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, MD, USA (2001). www.fda.gov/downloads/drugs/ guidance compliance regulatory information/guidance/ ucm070107.pdf
12. EMA. Concept paper/ recommendations on the need for a (CHMP) guideline on the validation of bioanalytical methods. EMA/ CHMP/ EWP/192217/2009 (2009). www.ema.europa.eu/docs/en-GB/ document-library/Scientific- guideline/2009/12/ WC500018062.pdf